PubMed Health⌕ Search

PubMed · 8557404

Computer model of human lung morphology to complement SPECT analyses.

Abstract

Aerosol therapy protocols could be improved if inhaled pharmacologic drugs were selectively deposited within the human lung. The targeted delivery to specific sites, such as receptors and sensitive airway cells, would enhance the efficacies of airborne pharmaceuticals. The high spatial discrimination of deposition patterns of inhaled particles can be determined via Single Photon Emission Computer Tomography (SPECT). However, major problems continue to compromise SPECT protocols. Our work focuses on two issues: how can the spatial discrimination be improved; and how are the images to be interpreted? We present a methodology, described by a mathematical model and supercomputer code, for systematically slicing through the human lung in a prescribed manner that is conducive to implementation into SPECT analyses. The lung is divided into concentric shells, or annuli, and the airway generation-by-generation composition of the respective shells determined. This identification was accomplished by superimposing the new shell structure with the 3-D branching network presented by Martonen et al. [23]. Perhaps the key aspect of the model-code is that the supercomputer is instructed to determine the 3-D spatial coordinates of each of the airways (over 16 million) of the lung with respect to the clinician-selected contours of shells within the lung.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T B Martonen, Y Yang, D Hwang, J S Fleming. 1995. Computer model of human lung morphology to complement SPECT analyses.. https://doi.org/10.1016/0020-7101(95)01106-o

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗